Cargando…

Discovery of new biomarkers for malignant mesothelioma

Malignant mesothelioma is an asbestos-induced, aggressive tumour with limited treatment options and very poor outcome. Currently, there are no tumour biomarkers in widespread clinical use for this disease. Soluble mesothelin is the most intensively investigated mesothelioma biomarker and has been ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Creaney, Jenette, Dick, Ian M., Robinson, Bruce W. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Pleural Diseases and Mesothelioma (G Lee, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356891/ https://www.ncbi.nlm.nih.gov/pubmed/25927434 http://dx.doi.org/10.1007/s13665-015-0106-8

Ejemplares similares

Management of Septated Malignant Pleural Effusions
por: Banka, Radhika, et al.
Publicado: (2018)

Chest Drain Size: the Debate Continues
por: Hallifax, Robert J., et al.
Publicado: (2017)

Thoracic Ultrasound: What Non-radiologists Need to Know
por: Williamson, Jonathan P., et al.
Publicado: (2017)

Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol
por: Hoon, Siao Nge, et al.
Publicado: (2020)

A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic
por: Church, Matt, et al.
Publicado: (2021)

Moral distress in mesothelioma and lung cancer nurses during the COVID-19 pandemic: insights from a UK survey
por: Hargreaves, Sarah, et al.
Publicado: (2023)

Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire
por: Senek, Michaela, et al.
Publicado: (2022)

Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: validation and comparison with modified RECIST response criteria
por: Kidd, Andrew C, et al.
Publicado: (2022)

Living beyond expectations: a qualitative study into the experience of long-term survivors with pleural mesothelioma and their carers
por: Johnson, Matthew, et al.
Publicado: (2022)

Systemic Treatments for Mesothelioma: Standard and Novel
por: Kindler, Hedy Lee
Publicado: (2008)

Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors
por: Kidd, Andrew C, et al.
Publicado: (2018)

Differentiation of malignant from benign pleural effusions based on artificial intelligence
por: Wang, Sufei, et al.
Publicado: (2023)

Critical analysis of the utility of initial pleural aspiration in the diagnosis and management of suspected malignant pleural effusion
por: Mercer, Rachel Mary, et al.
Publicado: (2020)

Efficacy of sonographic and biological pleurodesis indicators of malignant pleural effusion (SIMPLE): protocol of a randomised controlled trial
por: Psallidas, Ioannis, et al.
Publicado: (2017)

Indwelling pleural catheters for non-malignant pleural effusions: report on a single centre’s 10 years of experience
por: Frost, Nikolaj, et al.
Publicado: (2020)

Pre-EDIT: protocol for a randomised feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis (EDIT) in malignant pleural effusion
por: Martin, Geoffrey A, et al.
Publicado: (2018)

The randomised thoracoscopic talc poudrage+indwelling pleural catheters versus thoracoscopic talc poudrage only in malignant pleural effusion trial (TACTIC): study protocol for a randomised controlled trial
por: Dipper, Alexandra, et al.
Publicado: (2023)

Randomised controlled trial to compare the diagnostic yield of positron emission tomography CT (PET-CT) TARGETed pleural biopsy versus CT-guided pleural biopsy in suspected pleural malignancy (TARGET trial)
por: de Fonseka, Duneesha, et al.
Publicado: (2018)

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Auto-Antibodies to β-F1-ATPase and Vimentin in Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2011)

British Thoracic Society Training Standards for Thoracic Ultrasound (TUS)
por: Stanton, Andrew E, et al.
Publicado: (2020)

Providing safe and effective pleural medicine services in the UK: an aspirational statement from UK pleural physicians
por: Evison, Matthew, et al.
Publicado: (2018)

Safety and efficacy of ambulatory management of secondary spontaneous pneumothorax: a case series
por: Khan, Fasih, et al.
Publicado: (2019)

Pneumomediastinum in marijuana users: a retrospective review of 14 cases
por: Weiss, Zoe Freeman, et al.
Publicado: (2019)

Ensuring basic competency in chest tube insertion using a simulated scenario: an international validation study
por: Hertz, Peter, et al.
Publicado: (2018)

Assessment of patient-reported outcome measures in pleural interventions
por: Psallidas, Ioannis, et al.
Publicado: (2017)

Randomised Ambulatory Management of Primary Pneumothorax (RAMPP): protocol of an open-label, randomised controlled trial
por: Hallifax, Rob, et al.
Publicado: (2019)

Chest drain aerosol generation in COVID-19 and emission reduction using a simple anti-viral filter
por: Duffy, Clodagh, et al.
Publicado: (2020)

Pulmonary passport: a service evaluation study of a standardised web-based procedure logbook to aid specialist respiratory training and appraisal
por: Cheng, Andrew, et al.
Publicado: (2020)

Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
por: Kanellakis, Nikolaos I, et al.
Publicado: (2019)

Training opportunities in thoracic ultrasound for respiratory trainees: are current guidelines practical?
por: Stanton, Andrew E, et al.
Publicado: (2019)

Minimal clinically important difference for chest discomfort in patients undergoing pleural interventions
por: Dahlberg, Greta Jean, et al.
Publicado: (2020)

Incidence of bleeding in patients on different anticoagulants and antiplatelet therapies undergoing thoracentesis
por: Aljundi, Lamia, et al.
Publicado: (2021)

Diagnostic value and safety of thoracoscopic pleural biopsies in pleural exudative effusions of unknown origin, including follow-up
por: Deschuyteneer, Evan Patrick, et al.
Publicado: (2022)

Parapneumonic effusions related to Streptococcus pneumoniae: serotype and disease severity trends from 2006 to 2018 in Bristol, UK
por: Hyams, Catherine, et al.
Publicado: (2023)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo
por: Greening, David W., et al.
Publicado: (2016)

Successful treatment of a patient with oligometastatic mesothelioma to the brain
por: Li, Selena S., et al.
Publicado: (2020)

How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies
por: Robinson, Bruce W.S., et al.
Publicado: (2022)

Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum
por: Creaney, Jenette, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kvp20tp2l3u5t996hvr9ob50qn